Nuvation Bio
Latest round
- Series A
Last raised
- Oct 2019
Total raised
- $275M
Investors
- 12
About Nuvation Bio
Nuvation Bio, Inc. specializes in oncology medicine development. Founded in 2018 in New York, US, the firm has completed 2 transactions to date.00 mn, with the most recent deal occurring on March 3, 2025.Nuvation Bio, Inc. develops and commercializes innovative oncology medicines, specifically targeting difficult-to-treat cancers. Their flagship product, Taletrectinib (IBTROZI™), has received FDA approval for advanced ROS1+ non-small cell lung cancers. The company is committed to enhancing patient outcomes by addressing drug resistance and the shortcomings of existing therapies.Nuvation Bio's revenue is primarily generated through the commercialization of its FDA-approved therapies, particularly Taletrectinib (IBTROZI™).Nuvation Bio, Inc.S. commercial launch of Taletrectinib and to advance its clinical-stage pipeline. The company is targeting expansion into new geographical markets to enhance patient access to its therapies, with specific plans for launching in additional regions by 2025.
Who invested in Nuvation Bio
12 investors across 1 round
See all investors in Nuvation Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 28, 2019
Amount
$275M
Investors
Questions about Nuvation Bio
Who invested in Nuvation Bio?
Nuvation Bio has 12 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuvation Bio raised?
Nuvation Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nuvation Bio last raise money?
Nuvation Bio's most recent round on record is a Series A, in Oct 2019.
What does Nuvation Bio do?
Nuvation Bio is a biotechnology company.
Where is Nuvation Bio headquartered?
Nuvation Bio is headquartered in New York, US.
Which VCs invest in companies like Nuvation Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nuvation Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nuvation Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.